DE60228764D1 - R-bambuterol, seine herstellung und therapeutische verwendungen - Google Patents

R-bambuterol, seine herstellung und therapeutische verwendungen

Info

Publication number
DE60228764D1
DE60228764D1 DE60228764T DE60228764T DE60228764D1 DE 60228764 D1 DE60228764 D1 DE 60228764D1 DE 60228764 T DE60228764 T DE 60228764T DE 60228764 T DE60228764 T DE 60228764T DE 60228764 D1 DE60228764 D1 DE 60228764D1
Authority
DE
Germany
Prior art keywords
bambuterol
preparation
therapeutic uses
enantiomer
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60228764T
Other languages
German (de)
English (en)
Inventor
J L Cheng
Wen Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60228764D1 publication Critical patent/DE60228764D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE60228764T 2002-08-08 2002-08-08 R-bambuterol, seine herstellung und therapeutische verwendungen Expired - Lifetime DE60228764D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/025225 WO2004014290A2 (en) 2002-08-08 2002-08-08 R-bambuterol, its preparation and therapeutic uses

Publications (1)

Publication Number Publication Date
DE60228764D1 true DE60228764D1 (de) 2008-10-16

Family

ID=31713793

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228764T Expired - Lifetime DE60228764D1 (de) 2002-08-08 2002-08-08 R-bambuterol, seine herstellung und therapeutische verwendungen

Country Status (8)

Country Link
EP (2) EP1542672B1 (enExample)
JP (1) JP4979889B2 (enExample)
CN (1) CN100356913C (enExample)
AT (1) ATE406887T1 (enExample)
AU (1) AU2002332488A1 (enExample)
DE (1) DE60228764D1 (enExample)
ES (1) ES2312669T3 (enExample)
WO (1) WO2004014290A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100803291B1 (ko) 2006-09-08 2008-02-13 (주)팜스웰 밤부테롤 염산염의 개선된 제조방법
US20120082626A1 (en) * 2009-06-16 2012-04-05 Wen Tan Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
CN102617404A (zh) * 2012-04-06 2012-08-01 张长利 盐酸班布特罗及其中间体的制备工艺
CN103288670B (zh) * 2013-05-16 2014-11-05 南京医科大学第一附属医院 多羟基二苯甲酮衍生物及其应用
CN104478740B (zh) * 2014-11-19 2017-01-25 上海化工研究院 一种稳定同位素标记β受体激动剂类化合物的合成方法
CN104557614B (zh) * 2014-12-15 2017-01-04 广东东阳光药业有限公司 一种胺的还原方法
CN105254512B (zh) * 2015-11-10 2017-03-22 山东达因海洋生物制药股份有限公司 一种硫酸特布他林的制备方法
CN106831452A (zh) * 2017-02-15 2017-06-13 杭州百诚医药科技股份有限公司 一种硫酸特布他林的制备方法
CN107445866A (zh) * 2017-07-13 2017-12-08 上海昕盛医药科技有限公司 一种盐酸班布特罗杂质d的合成方法
CN107445867A (zh) * 2017-07-13 2017-12-08 上海昕盛医药科技有限公司 一种盐酸班布特罗杂质b的合成方法
AU2019315823A1 (en) * 2018-07-31 2021-04-01 Wen Tan New use of carbamate beta phenylethanolamine analogues for enhancing intracellular clearance of ldl cholesterol and for combining therapy with statins to enhance the efficacy and reduce adverse effects
CN109942462B (zh) * 2019-03-06 2022-01-14 宏冠生物药业有限公司 一种盐酸班布特罗的合成工艺
US20220362174A1 (en) * 2019-05-07 2022-11-17 Wen Tan Use of R-enantiomer Beta2-agonists for prevent and treatment of pulmonary inflammation and inflammatory remodeling for reduced adverse effects
CN115531368A (zh) * 2021-06-14 2022-12-30 谭文 R-氨基甲酸酯-β-苯乙醇胺类化合物治疗学习和记忆缺陷以及神经退行性疾病的应用
CN117586152A (zh) * 2023-11-23 2024-02-23 黑龙江乌苏里江制药有限公司 一种盐酸班布特罗的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1273A (en) * 1980-07-09 1985-03-08 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
CN100356913C (zh) 2007-12-26
AU2002332488A1 (en) 2004-02-25
JP2006503816A (ja) 2006-02-02
EP2002831A1 (en) 2008-12-17
EP1542672A2 (en) 2005-06-22
EP1542672B1 (en) 2008-09-03
ES2312669T3 (es) 2009-03-01
WO2004014290A3 (en) 2004-08-05
ATE406887T1 (de) 2008-09-15
EP1542672A4 (en) 2006-06-07
JP4979889B2 (ja) 2012-07-18
CN1638756A (zh) 2005-07-13
WO2004014290A2 (en) 2004-02-19
AU2002332488A8 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
DE602004022946D1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
ATE294171T1 (de) Phenylsulfonyl-1,3-dihydro-2h-indol-2-on derivate,deren herstellung und deren therapeutische verwendung
DE60228764D1 (de) R-bambuterol, seine herstellung und therapeutische verwendungen
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
NO20065904L (no) Terapeutiske forbindelser
EE05036B1 (et) Asendatud indoolid NFkB aktiivsuse moduleerimiseks, nende valmistamismeetod ja kasutamine ning ravim ja selle valmistamismeetod
NO20044054L (no) Administrering av midler for behandling av betennelse
PL374831A1 (pl) Zmodyfikowane proleki 2' i 3'-nukleozydowe do leczenia zakażeń Flaviviridae
DE69938791D1 (de) Orale methylphenidat-formulierungen mit kontrollierter/veränderter freisetzung
DE60107859D1 (de) Benzimidazolderivate, ihre herstellung und therapeutische verwendung
ATE232865T1 (de) 1,4-diazabicyclo(3.2.2)nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
DK1263504T3 (da) Anvendelse af forbindelser med 5-HT1A aktivitet, som er anvendelige til behandling af lidelser i den ydre retina
DE60307632D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
ATE409184T1 (de) Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung
ATE412635T1 (de) Diphenylpyridinderivate, deren herstellung und deren therapeutische anwendung
ATE312828T1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
NO20031648D0 (no) Farmasöytiske lösninger av modafinilforbindelser
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
EE200100623A (et) Melatoniini terapeutiline kasutamine
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
NO20042846L (no) Derivater av 5-(pyridin-3-yl)-1-azabicyklo[3.2.1]oktan, fremstilling derav og anvendelse av de samme som terapeutiske midler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition